The amount of equity flowing into companies developing mRNA-based vaccines has significantly declined so far in 2025, ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. recently terminated $500 million in federal funding for ...

CureVac's (CVAC) mRNA innovations, strong patent portfolio, and investment potential. Learn the risks and rewards of this ...

Moderna stock is trading higher Wednesday afternoon, lifted by positive sentiment across the pharmaceutical sector.

A new Korean study controversially links COVID vaccines to six types of cancer, including lung and prostate, with higher ...

President Donald Trump announced a deal with Pfizer to lower prescription drug costs through Medicaid, and a 'TrumpRx' ...

Pfizer's stock has been struggling for multiple years, and even a low valuation hasn't made it an enticing option for many ...

A substantial body of evidence supports the safety of the COVID-19 vaccines during pregnancy, contrary to the suggestions of ...

A newly developed vaccine that was found to prevent dangerous immune reactions and life-threatening inflammation in mice ...

Slashed budgets on both sides of the Atlantic will hinder the kind of life-saving science that may soon cure Huntington’s ...

The Department of Defense funds biomedical research to ensure military and pandemic preparedness. This includes mRNA vaccine ...

Clinical studies suggest these vaccines can generate immunological memory, allowing lymphocytes to respond to tumor ...